| Nov 14 |
INAB: Upcoming Presentations at SNO & ASH
|
| Nov 13 |
IN8bio GAAP EPS of -$0.15
|
| Nov 12 |
IN8bio Reports Third Quarter 2024 Financial Results and Recent Corporate Highlights
|
| Nov 12 |
IN8bio Announces Plenary Oral Presentation at the 2024 Society for Neuro-Oncology (SNO) Annual Meeting
|
| Nov 5 |
IN8bio Announces Upcoming Presentation at the 2024 American Society of Hematology (ASH) Annual Meeting
|
| Nov 4 |
IN8bio files secondary offering of common stock
|
| Oct 9 |
Why Saratoga Investment Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket
|
| Oct 2 |
INAB: Restructuring Narrows Focus to AML
|
| Oct 1 |
IN8bio dips 9%, prices $12.4M private placement
|
| Oct 1 |
IN8bio Announces Pricing of $12.4 Million Private Placement
|
